Canada markets closed

Lattice Biologics Ltd. (LBL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.04000.0000 (0.00%)
At close: 12:31PM EDT
Full screen
Previous Close0.0400
Open0.0400
Bid0.0400 x 0
Ask0.0450 x 0
Day's Range0.0400 - 0.0450
52 Week Range0.0300 - 0.1300
Volume84,316
Avg. Volume178,701
Market Cap5.129M
Beta (5Y Monthly)-12.08
PE Ratio (TTM)N/A
EPS (TTM)-0.0180
Earnings DateFeb. 28, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Lattice Announces Strategic Advisory Board

    Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice" or the "Company"), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected business leaders that will provide guidance to Lattice’s executive team as it continues to build and strengthen the Company's portfolio of cannabis and psilocybin related brands and products

  • Business Wire

    Lattice Announces Strategic Cannabis Supply Agreement With Firehouse

    Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice" or the "Company"), an emerging leader in psilocybin research and cannabis company, today announced it has entered into a Strategic Supply Agreement (the "Agreement") with Firehouse LLC ("Firehouse"), one of Montana’s most established medical cannabis producers.

  • Business Wire

    Lattice Biologics Reorganizes to Focus on Psychedelics and Cannabis Therapies

    Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice Biologics" or the "Company") announced today that the Company will change its business strategy to focus on the fast growing psychedelics and cannabis markets through the creation of a new life sciences subsidiary. The Company will focus on the research and commercialization of psychedelic products in combination with its stem cell based regenerative compounds while leveraging the Company’s distribution expertise.